Putman Media

Pharma QbD.com logo

www.pharmaqbd.com

Our Mission

Pharma QbD coverPharmaQbD advances a smarter approach to drug development—a more scientific, efficient and less “hit-and-miss” approach. It does this via peer-to-peer exchange of best practices, as well as solutions-oriented, actionable information and ideas to improve the drug development process. There is an urgent need for “best practices” for implementing Quality by Design (QbD) programs and thinking within the drug industry. Currently, as the pace of new drug introductions slows and some established “blockbusters” are found to have serious safety issues, it can take 10-12 years and $1 billion to develop a new drug. Drug makers need to optimize quality and safety, as well as “manufacturability” from the earliest stages of any drug’s development and to improve speed to market. This critical industry movement is being advanced by FDA, EMEA and other global regulatory agencies, and is a key part of the ICH’s (International Council for Harmonization) Q8, 9 and 10.

Led by Experts—PharmaQbD Editorial Advisory Board

PharmaQbD is honored to have the expertise and experience of numerous industry experts serving on the PharmaQbD Editorial Advisory Board:

  • Michael Kowolenko, Senior VP, Wyeth Biotech
  • John Avellanet, CEO, Cerulean Associates
  • Moheb Nasr, Director, Office of New Drug Quality Assessment, FDA
  • Ranjit Barshikar, GMP/Quality Consultant
  • Prabir Basu, Executive Director, National Institute for Pharmaceutical Technology and Education
  • Bihash Chatterjee, President, Pharmatech Associates
  • Joseph De Feo, CEO, Juran Institute
  • Alistair Gillanders, CTO and VP North America, DynoChem
  • Steve Jolley, Vice President of Pharmacovigilance, Patni Life Sciences
  • Jason Kamm, Principal, Tunnell Consulting
  • Michael Meagher, Professor, University of Nebraska-Lincoln
  • Justin Neway, CSO, Aegis Analytical
  • Rakesh Patel, Assistant Professor, Ganpat University, India
  • Russ Somma, President, SommaTech, Inc.

PharmaQbD.com Audience by Title

  • Scientists
    • Chief Scientist
    • Members of the Technical Staff
  • Director, Manager, VP, SVP of:
    • Process development
    • Product development
    • Technology transfer
    • Research and Development
    • Business development
    • Clinical R&D
    • Clinical safety and pharmacovigilance
    • Clinical manufacturing
    • Clinical supply operations
    • Clinical trial and project management
    • Chemical Manufacturing Control (CMC)
    • Compliance
    • Quality Assurance and Control
    • Outsourcing
    • Regulatory affairs
    • Risk management
    • Strategic planning and alliance development
    • Manufacturing and Operations
    • Engineers
  • “C” Level Executives
    • CEO
    • President
    • CFO
    • COO

Mission

PharmaQbD advances a smarter approach to drug development—a more scientific, efficient and less “hit-and-miss” approach. It does this via peer-to-peer exchange of best practices, as well as solutions-oriented, actionable information and ideas to improve the drug development process. There is an urgent need for “best practices” for implementing Quality by Design (QbD) programs and thinking

Learn more

Market

Catalysts for improving the pharmaceutical industry! Development thru manufacturing. The pharmaceutical industry is faced with numerous business pressures forcing the need for increased efficiencies and operational improvements in every area. While pharmaceutical companies are businesses and must strive to generate profits, the business of the pharmaceutical industry is to save and improve quality of life

Learn more

Website

Do You Want to Interface With 6,000 Pharmaceutical Industry Executives Following and Shaping the Quality by Design Movement? The pharmaceutical industry’s Quality by Design movement is evolving and PharmaQbD.com is evolving as well. Now 3 years old, PharmaQbD.com has secured a loyal audience of thought-leaders within the Quality by Design movement. 5,500 – 6,000 pharmaceutical

Learn more

E-News

E-Newsletter Sponsorship PharmaQbD.com’s e-newsletters can help you reach thousands of buyers and achieve a high return on your investment. Containing original topical features, the latest industry news and technical insights, our e-newsletters give you high response rates from your key prospects. PharmaQbD.com E-News A news-focused update that delivers feature articles, headlines with direct links to

Learn more

Multimedia

Webinars What Are Webinars? Webinars are streaming media presentations that feature synchronized audio and PowerPoint slides in an interactive format where the audience can ask questions of the presenters. Most often done live, attendees register beforehand to attend these free, roughly one-hour online discussions via their computers. The discussions are recorded and are then available

Learn more

Lead Gen

PharmaQbD‘s unique lead-generation programs are based on best practices in permission marketing: offer high-value content related to a specific technology purchase decision or topic, and interested prospects will offer their contact information in exchange, giving you implicit permission to market to them. Program mechanics are relatively straightforward: Your company sponsors and/or supplies an appropriate piece

Learn more

Advertising

Welcome and thank you for your interest in Pharma QdD! You are currently on the Online Media Kit of Pharma QbD. From here, you can navigate through the links below to gain access to all the information you need to create your marketing campaign. Please feel free to explore the other links for additional information

Learn more

Contacts

Need to submit an ad or contact your sales representative; go here to locate the contact information of your PharmaQbD staff.

Learn more